Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sygrid van der Zee

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
BMC Neurology|June 15, 2020
Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiologyJeffrey M Boertien, Sygrid van der Zee, Asterios Chrysou, et al.
Molecular Pharmaceutics|March 15, 2022
No Dopamine Agonist Modulation of Brain [<sup>18</sup>F]FEOBV Binding in Parkinson's DiseaseRoger L Albin, Prabesh Kanel, Teus van Laar, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 6, 2020
Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network HubsPrabesh Kanel, Martijn L T M Müller, Sygrid van der Zee, et al.
Brain : a Journal of Neurology|September 25, 2023
Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patientsSofie Slingerland, Sygrid van der Zee, Giulia Carli, et al.
Journal of Parkinson'S Disease|February 27, 2018
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body DiseaseSygrid van der Zee, Yannick Vermeiren, Erik Fransen, et al.
Aging Brain|April 25, 2022
Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [<sup>18</sup>F]FEOBV PET studyPrabesh Kanel, Sygrid van der Zee, Carlos A Sanchez-Catasus, et al.
Parkinsonism & Related Disorders|November 16, 2021
Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathologyMuhammad Nazmuddin, Jan-Willem van Dalen, Ronald J H Borra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2026
Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's DiseaseSofie Slingerland, Sygrid van der Zee, Sven C D van Ijzendoorn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 17, 2022
Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive ImpairmentSygrid van der Zee, Prabesh Kanel, Marleen J J Gerritsen, et al.
Brain : a Journal of Neurology|March 4, 2024
Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypesNiels Okkels, Michel J Grothe, John-Paul Taylor, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
BMC Neurology|June 15, 2020
Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiologyJeffrey M Boertien, Sygrid van der Zee, Asterios Chrysou, et al.
Molecular Pharmaceutics|March 15, 2022
No Dopamine Agonist Modulation of Brain [<sup>18</sup>F]FEOBV Binding in Parkinson's DiseaseRoger L Albin, Prabesh Kanel, Teus van Laar, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|June 6, 2020
Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network HubsPrabesh Kanel, Martijn L T M Müller, Sygrid van der Zee, et al.
Brain : a Journal of Neurology|September 25, 2023
Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patientsSofie Slingerland, Sygrid van der Zee, Giulia Carli, et al.
Journal of Parkinson'S Disease|February 27, 2018
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body DiseaseSygrid van der Zee, Yannick Vermeiren, Erik Fransen, et al.
Aging Brain|April 25, 2022
Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [<sup>18</sup>F]FEOBV PET studyPrabesh Kanel, Sygrid van der Zee, Carlos A Sanchez-Catasus, et al.
Parkinsonism & Related Disorders|November 16, 2021
Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathologyMuhammad Nazmuddin, Jan-Willem van Dalen, Ronald J H Borra, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2026
Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's DiseaseSofie Slingerland, Sygrid van der Zee, Sven C D van Ijzendoorn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 17, 2022
Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive ImpairmentSygrid van der Zee, Prabesh Kanel, Marleen J J Gerritsen, et al.
Brain : a Journal of Neurology|March 4, 2024
Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypesNiels Okkels, Michel J Grothe, John-Paul Taylor, et al.
Pageof 3